Zhongchao Inc is a health information services business based in the US. Zhongchao shares (ZCMD) are listed on the NASDAQ and all prices are listed in US Dollars. Zhongchao employs 88 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $1.74 |
|---|---|
| 52-week range | $1.46 - $2.86 |
| 50-day moving average | $1.81 |
| 200-day moving average | $1.75 |
| Wall St. target price | N/A |
| PE ratio | 11.25 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $0.16 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.74 from 2022-01-25
| 1 week (2022-01-19) | -4.92% |
|---|---|
| 1 month (2021-12-23) | -4.40% |
| 3 months (2021-10-26) | 2.96% |
| 6 months (2021-07-26) | 5.45% |
| 1 year (2021-01-26) | -10.31% |
|---|---|
| 2 years (2020-01-22) | N/A |
| 3 years (2019-01-22) | N/A |
| 5 years (2017-01-22) | N/A |
Valuing Zhongchao stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Zhongchao's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Zhongchao's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 11x. In other words, Zhongchao shares trade at around 11x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Zhongchao's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.7 million.
The EBITDA is a measure of a Zhongchao's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $18.1 million |
|---|---|
| Operating margin TTM | 19.12% |
| Gross profit TTM | $11.9 million |
| Return on assets TTM | 6.46% |
| Return on equity TTM | 13.31% |
| Profit margin | 22.06% |
| Book value | $1.33 |
| Market capitalisation | $42.5 million |
TTM: trailing 12 months
We're not expecting Zhongchao to pay a dividend over the next 12 months.
Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand. The company operates through its mdmooc. org online platform under the MDMOOC brand; and Sunshine Health Forums, a Wechat subscription account and mobile app. It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers.
Bitcoin breached the $40,000 price level and may plummet lower as Russia signals a potential ban.
Cardano’s first metaverse project is available to investors now — if you can find a piece of digital land on sale. Plots sold fast despite the project’s early stage limitations.
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.